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Abstract
Background—Cigarette smoking increases the risk of coronary heart disease, but whether
smoking increases atrial fibrillation (AF) is uncertain.
Objectives—To determine the association of cigarette smoking with incident AF in a
population-based cohort of blacks and whites.
Methods—We determined the risk of incident AF through December 2002 in relation to baseline
(1987–1989) smoking status and cigarette-years of smoking in over 15,000 participants of the
prospective Atherosclerosis Risk in Communities study.
Results—Over a mean follow-up of 13.1 years, 876 incident AF events were identified.
Compared to never smokers, the multivariable-adjusted hazard ratios (HR) for AF were 1.32 (95%
CI, 1.10–1.57) in former smokers, 2.05 (95% CI, 1.71–2.47) in current smokers, and 1.58 (95%
CI, 1.35–1.85) in ever smokers. In the highest tertile of accumulated smoking amount (>675
cigarette-years), the incidence of AF was 2.10-times greater (95% CI, 1.74–2.53) than those who
never smoked. Associations were similar by gender, race, and type of event (AF and atrial flutter),
and also when only AF events identified by study exam ECGs were included. Finally, individuals
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who quit smoking exhibited a trend indicating a slightly lower risk of developing AF (HR, 0.88;
95% CI, 0.65–1.17) compared to those who continued to smoke.
Conclusions—Smoking was associated with the incidence of AF, with more than a 2-fold
increased risk of AF attributed to current smoking. In addition, a trend toward a lower incidence of
AF appeared among smokers who quit compared to continued smokers.
Keywords
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INTRODUCTION
Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice and
currently affects more than 2.2 million Americans.1 Risk factors for AF include increasing
age, male gender, white race, obesity, hypertension, and diabetes;2 more recently, the
metabolic syndrome has also been implicated in the development AF.3 However, other
important cardiovascular risk factors, such as elevated cholesterol and cigarette smoking are
less clearly related to AF. Specifically, cigarette smoking has been shown to predict one’s
individual risk for AF in a risk score developed using the Atherosclerosis Risk in
Communities (ARIC) study;4 however, results from other prospective studies investigating
the association between smoking and AF have provided inconsistent results.
In the Framingham Heart Study, cigarette smoking conferred a 40% increased odds of
developing AF among women, but there was no association among men.5 Furthermore,
current smoking was not a significant predictor for AF in the Framingham risk score for
AF.6 Compared with never smokers, the Rotterdam study reported a 51% and 49% increased
risk of incident AF among current and former smokers, respectively, which did not differ by
gender.7 A 37% increased risk of AF among ever smokers was reported in the Manitoba
Follow-Up Study.8 Yet, no association was found between smoking and AF in the Danish
Diet, Cancer, and Health Study9 or the Multifactor Primary Prevention Study.10
Though cigarette smoking increases oxidative stress,11 inflammation,11 and atrial fibrosis,12
all mechanisms potentially involved in the etiology of AF,13 these limited and inconsistent
data suggest further investigation of the association between smoking and AF is warranted.
Thus, we assessed in detail the risk of incident AF in relation to smoking status and amount
in the ARIC study.
METHODS
Study Population
The ARIC study is a prospective investigation aimed to identify risk factors for
atherosclerosis and cardiovascular disease. ARIC recruited adults aged 45–64 years from
four US communities: Forsyth County, NC; Jackson, MS; Minneapolis suburbs, MN; and
Washington County, MD.14 Blacks and whites were recruited from Forsyth County, only
blacks from Jackson, and predominantly whites from the other two communities. Between
1987 and 1989, 15,792 participants (8710 women) were enrolled, completing a home
interview and clinic visit. Three triennial follow-up clinic visits were conducted, and annual
telephone interviews and active surveillance of the ARIC community hospitals are
conducted to follow-up participants. The ARIC study was approved by institutional review
boards at each participating center, and informed consent was obtained from all participants.
Chamberlain et al. Page 2














Electrocardiograms (ECGs) during the baseline visit were used to exclude individuals with
prevalent AF or atrial flutter. Incident AF diagnoses were identified from ECGs performed
during study follow-up visits through 1998, and hospital discharge records and death
certificates through 2005.
ARIC examination ECGs were recorded using MAC PC Personal Cardiographs (Marquette
Electronics, Inc., Milwaukee, WI). At each clinic visit, a standard supine 12-lead resting
ECG was recorded, at least one hour after smoking tobacco or ingestion of caffeine. ECGs
were transmitted by modem to the ARIC ECG Reading Center for computer coding, and
those computer-coded as AF were visually re-checked by a cardiologist to confirm the
diagnosis.15
Annual follow-up telephone calls to cohort participants and survey of local hospitals
identified hospitalizations or deaths. Hospital discharge records were gathered from all
hospitalizations, and AF was identified by an ICD-9 discharge code of 427.31 or 427.32
among any of the discharge diagnoses. AF was also identified when any listed cause of
death on a death certificate was coded as AF (ICD-9 code 427.3 or ICD-10 code I48). AF
occurring simultaneously with heart revascularization surgery (ICD-9 code 36.X) or other
cardiac surgery involving heart valves or septa (ICD-9 code 35.X) was not considered an
incident event. Within the ARIC cohort, the sensitivity and specificity of hospital discharge
diagnoses for AF was found to be 84% and 98%, respectively.16
Smoking Assessment
Cigarette smoking status and amount were self-reported. Participants were asked whether
they ever smoked cigarettes, and if so, the age of smoking initiation, number of years of
smoking, number of cigarettes smoked per day, and whether they currently smoked, and if
not, the age of cessation. From responses to these questions, participants were categorized as
current, former, or never smokers, and cigarette-years of smoking were calculated for ever
smokers.
We categorized smoking status using three classifications: 1) current, former, never
(reference), 2) ever, never (reference), and 3) current, non-current (reference). Cigarette-
years of smoking were categorized into tertiles for ever smokers, and never smokers served
as the reference group. In addition, current and former smokers were dichotomized at 800
cigarette-years of smoking (equivalent to 40 pack-years), with never smokers as the
reference.
Additional Baseline Measurements
Race, education level, and alcohol drinking status were determined by self-report. The sports
index for physical activity during leisure time ranged from 1 (low) to 5 (high), and was
based on the questionnaire developed by Baecke et al.17 Body mass index (BMI) was
calculated as weight (in kilograms) divided by height (in meters) squared. A participant was
categorized as diabetic if he/she had a fasting glucose ≥126 mg/dL (or non-fasting glucose
of ≥200 mg/dL), reported a physician diagnosis of diabetes, or was currently taking
medication for diabetes. The average of the last 2 of 3 blood pressure measurements of ≥140
mmHg systolic and/or ≥90 mmHg diastolic, or blood pressure medication use in the past 2
weeks defined hypertension. Prevalent coronary heart disease (CHD) included a history of
myocardial infarction (MI), MI indicated on the baseline ECG, or history of coronary bypass
or angioplasty. Prevalent heart failure (HF) was identified by the Gothenburg criteria18 or
self-report of HF medication use in the past 2 weeks.
Chamberlain et al. Page 3














Analyses were conducted using SAS version 8.2 (SAS Institute, Cary, NC). We excluded
individuals who were not of black or white race (N=48), blacks from Minneapolis and
Washington County (N=55), prevalent AF or missing AF status at baseline (N=261), and
those with unreadable baseline ECGs (N=85). We additionally excluded those with missing
or unknown smoking status (N=14) and/or missing cigarette-years of smoking (N=265) at
baseline in models where appropriate.
Baseline participant characteristics by smoking status were compared using the chi-square
statistic and analysis of variance (ANOVA). Kaplan-Meier methods were used to estimate
the cumulative incidence of AF. Age- and sex-adjusted incidence rates for AF were
calculated using Poisson regression. Hazard ratios for AF were estimated using Cox
proportional hazards regression after adjusting for baseline age, sex, race, ARIC field center,
education (less than high school, high school graduate to vocational school, any college),
BMI, alcohol drinking status (current, former, never), sports index (≥3.5, <3.5), diabetes,
and hypertension.
In a number of additional analyses, we tested the sensitivity of our results to the definition of
AF event. First, we conducted separate analyses for AF events identified from hospital
discharge codes and from ECGs in the study exams. Second, we explored whether
association of smoking was different for events coded as atrial flutter (ICD9 427.32) or AF
only (ICD9 427.31). Finally, we excluded AF events associated with non-cardiac chest or
abdominal surgery.
We also created an additional five cohorts using exams 2–4 and follow-up telephone
contacts 3 and 6 years after exam 4 as baseline. For each cohort, we excluded individuals
with prevalent AF and began follow-up at the date of the exam/telephone contact. We
adjusted for the same potential confounders as measured during the follow-up exams, using
exam 4 confounders for the cohorts 3 and 6 years after exam 4. For a particular cohort, we
categorized individuals as quitting smoking if they were current smokers at the previous
exam and former at the current exam; current smokers at both exams served as the reference.
These five cohorts were pooled into one Cox model using a robust variance estimator to take
into account within-individual correlations since study participants could be included more
than once.19
To test the proportional hazards assumption for the Cox regression models, interaction terms
between smoking status/amount and log of follow-up time were tested and the log-log
survival curves were plotted. The proportional hazards assumption was met for the first 16
years of follow-up, but not thereafter. Therefore, we did administrative censoring at
December 31, 2002 for all analyses.
RESULTS
After exclusions, 15,329 ARIC participants were available for the smoking status analysis,
and 15,078 were available for the cigarette-years and the combined smoking status and
amount analyses. Current and former smokers were less well educated, more likely to be
current drinkers, were less physically active, and had more prevalent CHD and HF than
never smokers (Table 1).
Over a mean follow-up of 13.1 years, 876 incident AF events were identified. Of these, 749
were ascertained by hospital discharge diagnoses alone, 17 from a study ECG alone, 105
from both a study ECG and a hospital discharge diagnosis, 1 from a death certificate alone,
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3 from hospital discharge diagnoses and a death certificate, and 1 from all 3 sources. AF was
the primary diagnosis in 351 of 858 events identified from hospitalizations.
The cumulative incidence of AF was 5.7% in never smokers and 9.8% in ever smokers
(Figure 1). The age- and sex-adjusted incidence rates for AF were 28 and 41 per 10,000
person-years in never and ever smokers, respectively (Table 2). The incidence of AF was
1.58-times (95% CI, 1.35–1.85) higher in ever compared to never smokers. In addition, the
risk of AF was 1.32-times (95% CI, 1.10–1.57) greater among former smokers and was 2-
fold higher in current smokers (HR, 2.05; 95% CI, 1.71–2.47) than never smokers. Hazard
ratios were similar by race (HR, 1.57; 95% CI, 1.32–1.88 in whites and HR, 1.60; 95% CI,
1.12–2.29 in blacks for ever vs. never smoking), although the incidence rates were lower in
blacks than whites (Table 3).
In a sensitivity analysis including only AF events identified by ECG during ARIC exams,
the increased risk of AF associated with smoking remained. The multivariable-adjusted
hazard ratios for ECG-diagnosed AF were 1.78 (95% CI, 1.10–2.87) in former, 2.45 (95%
CI, 1.44–4.16) in current, and 1.99 (95% CI, 1.27–3.12) in ever smokers compared to never
smokers. Additional sensitivity analyses excluding AF events associated with non-cardiac
chest or abdominal surgery, and subgroup analyses by gender and by type of event (AF,
atrial flutter) yielded similar results as our primary analyses (data not shown).
Because CHD and HF may be mediators, yet may also confound the association between
smoking and AF, we additionally ran models 1) censoring for CHD and HF during follow-
up and 2) adjusting for prevalent CHD and HF at baseline. When excluding prevalent CHD/
HF at baseline and censoring incident CHD or HF during follow-up, associations were
attenuated, indicating that CHD and HF may account for some of the association of smoking
with AF. Compared to never smokers, the hazard ratios (95% CI) were 1.23 (0.98–1.54) in
former, 1.62 (1.27–2.06) in current, and 1.37 (1.12–1.67) in ever smokers. In models
adjusting for CHD and HF at baseline, the hazard ratios (95% CI) of AF were 1.30 (1.09–
1.55), 1.98 (1.64–2.38), and 1.54 (1.31–1.81) in former, current, and ever smokers compared
to never smokers.
We also created tertiles of cigarette-years of smoking, and those in the lowest tertile had
similar risk of developing AF as never smokers (Table 2). Those in the second tertile had an
incidence rate of 41 per 10,000 person-years and a 60% increased risk of developing AF
(95% CI, 30%–95%). The heaviest smokers (>675 cigarette-years) exhibited an incidence
rate of 55 per 10,000 person-years and a hazard ratio of 2.10 (95% CI, 1.74–2.53) compared
to never smokers. With further adjustment for prevalent CHD and HF at baseline, the hazard
ratio for AF among the heaviest smokers was 1.94 (95% CI; 1.60–2.35).
We dichotomized current and former smokers into light/moderate versus heavy smokers
(<800 vs. ≥800 cigarette-years) (Table 4). Former smokers had lower incidence rates and
hazard ratios for AF compared to current smokers with similar cigarette-years of smoking.
Among those with <800 cigarette-years, former and current smokers had hazard ratios of
1.16 (95% CI, 0.96–1.40) and 1.85 (95% CI, 1.49–2.30), respectively. In heavy smokers of
≥800 cigarette-years, former smokers had a 89% increased risk, whereas current smokers
had a 131% increased risk of developing AF compared to never smokers.
In an attempt to further explore the association of quitting smoking with AF risk, we created
5 cohorts, using exams 2, 3, and 4, and annual telephone contacts 3 and 6 years past exam 4
as baseline, and pooled them in a Cox model. This analysis included 5,607 individuals and
326 AF cases. Individuals who quit smoking had a slightly lower, although statistically
nonsignificant, risk of developing AF (HR, 0.88; 95% CI, 0.65–1.17, p-value=0.38)
compared to those who continued to smoke.
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In this population-based prospective study with up to 16 years of follow-up, former and
current smokers exhibited a 32% and 105% increased risk of developing AF compared to
never smokers. The risk of incident AF increased with increasing cigarette-years of
smoking, and appeared to be somewhat greater among current smokers than former smokers
with similar cigarette-years of smoking.
Our results corroborate the findings reported in the Framingham Heart Study,5 the
Rotterdam Study,7 and the Manitoba Follow-up Study,8 prospective studies with similar
design and inclusion criteria to the ARIC cohort. However, our results indicate an even
stronger association between current smoking and incidence of AF than those previously
reported. In the ARIC study, we reported more than a 2-fold increased risk of AF among
current vs. never smokers, an estimate 50% greater than that reported in the Rotterdam
Study. In addition, we have found a much higher risk among current smokers compared to
former smokers, whereas the Rotterdam Study reported almost identical associations for
former and current smokers (HR of 1.51 (1.07–2.12) and 1.48 (1.12–1.96) for current and
former smokers, respectively).
Although our results in the ARIC study support those found in 3 other cohort studies, 2
Scandinavian studies did not find an association between smoking and risk of incident AF.
Several factors may have led to masking of associations between smoking and AF in the
Scandinavian studies, however. First, the Multifactor Primary Prevention Study10 included
an intervention for smoking cessation and only baseline data were used in analyses. Smokers
may have been more likely to quit or decrease their amount of smoking over follow-up,
potentially masking an association between smoking and AF. Second, the Danish Diet,
Cancer, and Health Study9 had the shortest follow-up of all studies (mean of 5.7 years) and
also the most stringent exclusion criteria. Participants who were hospitalized prior to
baseline for endocrine diseases or cardiovascular diseases were excluded. These exclusions
created a healthier cohort, and possibly eliminated those who smoked heavily or who may
have been more susceptible to the effects of smoking.
Several acute effects of smoking may be involved in the initiation of AF. Nicotine in
cigarettes increases heart rate and blood pressure,20 mainly as a consequence of increases in
plasma catecholamine concentrations due to nicotine stimulating sympathetic
neurotransmission.21 In addition, nicotine-induced alteration of atrial myocyte ion channel
conduction, either by release of neurotransmitters or by direct interaction with ion channels,
may increase vulnerability to fibrillation. Nicotine has been shown to block the transient
outward K+ current (Ito), which governs the initial phase of cardiac repolarization and
influences other currents and membrane transport processes.22 The blockage of Ito may be
proarrhythmic due to a delay of ventricular repolarization or prolongation of the effective
refractory period.
Some chronic effects of cigarette smoke may also play a role in the development of AF, as
indicated by the increased risk of AF among former smokers in our study. For example,
nicotine may contribute to the development of atrial fibrosis, which has been shown to favor
the occurrence of atrial arrhythmias.12 Interstitial fibrosis causes a substantial slowing of
electrical impulse propagation in cardiac tissue and affects chamber geometry.23 A recent
canine model of atrial fibrillation showed that nicotine causes downregulation of atrial
microRNA’s miR-133 and miR-590 in atrial fibroblasts, with an associated upregulation of
transforming growth factors TGF-β1 and TGF-βRII and increased collagen production,
inducing a proarrhythmic atrial fibrosis.24
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Finally, smoking may predispose to AF indirectly through the development of other
diseases. In some cases, the development of myocardial infarction due to a hypercoagulable
state, enhanced thrombosis, or hemodynamic stress as a result of smoking25 may increase
the risk of subsequently developing AF. In addition, reduced lung function and chronic
obstructive pulmonary disease (COPD) have been reported to increase the risk of AF;26, 27
therefore, the association of smoking and AF may also be in part mediated by reduced lung
function or COPD.
Our study has several strengths, including the large sample size, long follow-up, geographic
diversity, and biracial composition of the ARIC cohort. The large number of AF events
compares favorably with previous publications, and allowed to obtain more precise
estimates of the association of smoking status and amount with AF risk. Also, ours is the
first study to show an association between smoking and AF risk among blacks. However, we
also acknowledge some limitations. Some incident AF events among individuals without
symptoms, those who had paroxysmal AF, or those who were not hospitalized were
probably missed. In our study, most AF events were ascertained by hospital discharge
records, which could lead to AF underascertainment. However, in a sensitivity analysis
including only AF events identified during exam ECGs, we found that the hazard ratios for
AF by smoking status categories were slightly stronger than the associations found when
considering all AF cases, suggesting that case ascertainment alone could not explain the
observed associations. Two additional findings support the validity of AF ascertainment in
our study. First, AF rates in ARIC are similar to those reported by other cohorts, including
studies, such as the Framingham Heart Study, that relied more on study exam ECGs for
ascertainment of AF events.5, 27–30 Second, the association of variants in the 4q25
chromosomal region with AF risk in the ARIC study is of similar magnitude to associations
found in other cohorts that relied more on ECGs to identify AF events.31 Finally, although
we attempted to investigate the impact of smoking cessation on AF risk, we lacked adequate
information on reasons for quitting smoking and on confounders past ARIC visit 4. Thus,
residual confounding might explain the weak association between smoking cessation and
subsequent AF risk.
In conclusion, current smokers had twice the risk of developing AF over up to 16 years of
follow-up compared to never smokers. In addition, the risk of developing AF increased with
increasing cigarette-years of smoking, and current smokers appeared to have a greater risk
of AF than former smokers with similar cigarette-years of smoking. We found that the
associations between smoking and AF do not differ between blacks and whites, even though
the incidence rates of AF are lower among blacks compared to whites. Furthermore, among
smokers with similar cigarette-years of smoking, a nonsignificant trend toward a lower
incidence of AF in smokers who quit compared to continued smokers appeared. Future
studies should identify underlying biological mechanisms and determine the role of smoking
cessation in the prevention of AF.
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Table 1
Baseline Participant Characteristics by Smoking Status, ARIC 1987–89
Current (N=4005) Former (N=4950) Never (N=6374)
Age, years 53.6 (5.7) 54.8 (5.8) 54.0 (5.8)
Male 1900 (47.4) 3054 (61.7) 1915 (30.0)
Black 1214 (30.3) 962 (19.4) 1880 (29.5)
Education
 < High school 1243 (31.1) 1075 (21.7) 1302 (20.4)
 HS to vocational school 1649 (41.2) 1948 (39.4) 2661 (41.8)
 Any college 1107 (27.7) 1924 (38.9) 2403 (37.8)
Drinking status
 Current 2535 (63.6) 3141 (63.7) 2883 (45.4)
 Former 879 (22.0) 1170 (23.7) 835 (13.2)
 Never 574 (14.4) 623 (12.6) 2629 (41.4)
BMI, kg/m2 26.4 (5.0) 28.0 (5.1) 28.3 (5.7)
Sports index
 <3.5 3581 (89.7) 4067 (82.4) 5582 (87.9)
 ≥3.5 410 (10.3) 870 (17.6) 768 (12.1)
Diabetes 421 (10.6) 588 (11.9) 803 (12.7)
Hypertension 1291 (32.2) 1713 (34.8) 2316 (36.5)
Coronary heart disease 208 (5.3) 367 (7.5) 160 (2.6)
Heart failure 217 (5.5) 235 (4.8) 257 (4.1)
Cigarette-years of smoking 670.8 (430.9) 463.6 (434.1) 0 (0)
Values are mean (SD) for continuous variables and N (%) for categorical variables.
All characteristics differed among smoking groups at p<0.01.
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